Inovio Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

26.04.18	Hospital and Commercial Labs to Get Educated on Key Reforms to Order Processing at Executive War College (PR Newswire)
10.08.17	Honeywell Connected Aircraft Software Reduces Fuel Use For Two National Carriers By Up To 5 Percent (PR Newswire)
27.07.17	Alexander & Baldwin Announces Second Quarter 2017 Earnings Release And Webcast (PR Newswire)
11.01.17	Fabletics Re-Launches "The Core" (PR Newswire)
21.10.13	Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial (PR Newswire)
04.10.13	Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc. (PR Newswire)
01.10.13	Inovio Pharmaceuticals to Participate in Immunotherapy Panel and Present at the 12th Annual BIO Investor Forum (PR Newswire)
18.09.13	Inovio Pharmaceuticals to Present at Investor Conferences and Town Hall Los Angeles (PR Newswire)
10.09.13	Inovio Pharmaceuticals to Hold Investor Conference Call to Discuss Partnership with Roche (PR Newswire)
03.09.13	Inovio Pharmaceuticals to Present at Upcoming Investor Conferences (PR Newswire)
29.08.13	Today's Research: Inovio Pharmaceuticals Inc., Onyx Pharmaceuticals Inc., Sequenom Inc. and Optimer Pharmaceuticals Inc. (PR Newswire)
15.08.13	Inovio Pharmaceuticals' Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models (PR Newswire)
06.08.13	Inovio Pharmaceuticals Responds to Market Activity (PR Newswire)
10.01.11	Spotify Arrives on Logitech Squeezebox (Businesswire)
17.11.10	Inovio Pharmaceuticals’ HIV DNA Vaccine Achieves Strong T-Cell Immune Responses in Phase I Human Trial (Businesswire)
28.09.10	PRIMEDIA Becomes Founding Member of Alliance for Community Trees Corporate Leadership Council (Businesswire)
10.09.10	Kahn Swick & Foti, LLC and Former Louisiana Attorney General Notify XenoPort Shareholders With Large Financial Interests of Securities Fraud Class Action - XNPT (Businesswire)
16.06.10	Checkpoint Systems, Inc. Announces the Retirement of Board Member Alan R. Hirsig (Businesswire)
17.05.10	AngioDynamics Launches First Product in Morpheus® Smart PICC Series, a Triple Lumen Version for CT Imaging (Businesswire)
29.03.10	DNA Vaccine Company Inovio Biomedical Reports Fourth Quarter and Year-Ended 2009 Financial Results (Businesswire)
02.03.10	Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials (Businesswire)
23.02.10	Inovio Biomedical to Present at DNA Vaccines 2010 Conference (Businesswire)
08.02.10	Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial (Businesswire)
16.11.09	Therapeutic DNA Vaccine Company Inovio Biomedical Reports Third Quarter 2009 Financial Results (Businesswire)
05.10.09	Inovio Biomedical Therapeutic Cervical Cancer Vaccine Demonstrates Safety and Immunogenicity in Clinical Trial (Businesswire)
29.07.09	Inovio Biomedical Universal Influenza Vaccines Demonstrate 100% Protection Against Current Pandemic A/H1N1 Influenza Viruses in Animal Studies (Businesswire)
30.06.09	Inovio Biomedical, National Microbiology Laboratory, and University of Pennsylvania to Evaluate Candidate DNA Vaccines against "Swine” Influenza A (H1N1) (Businesswire)
04.06.09	Inovio Biomedical to Present at 8th Annual Needham Life Sciences Conference (Businesswire)
01.06.09	Inovio Biomedical Closes Merger with VGX Pharmaceuticals to Form a Leading Vaccine Discovery, Development and Delivery Company (Businesswire)
17.12.08	Inovio Biomedical’s Advances in Electroporation-Delivered Therapeutic Vaccines Presented at International DNA Vaccine Conference (Businesswire)
02.12.08	First-Ever Human Trial of DNA-Based Immunotherapy Delivered Using Inovio Biomedical’s Electroporation Technology Shows Safety and Durable Systemic Clinical Response (Businesswire)
05.06.08	Inovio Biomedical Provides Updated Interim Data on Phase I/II Clinical Study of Electroporation-Delivered Prostate Cancer DNA Vaccine at ASGT Annual Meeting (Businesswire)
09.05.08	Therapeutic DNA Vaccine Company Inovio Biomedical Reports First Quarter 2008 Financial Results (Businesswire)
04.04.08	Prostate Cancer DNA Vaccine Results in Higher T-Cell Response When Delivered via Inovio Biomedical's Electroporation Delivery System (Businesswire)
11.03.08	Inovio Biomedical's Electroporation Delivery Technology Demonstrates Safety and Positive Clinical Responses with Melanoma DNA Immunotherapy (Businesswire)
20.02.08	Therapeutic DNA-Vaccine Company Inovio Biomedical Appoints Dr. Stephen Rietiker as a Director (Businesswire)
20.02.08	Therapeutic DNA-Vaccine Company Inovio Biomedical Appoints Dr. Stephen Rietiker as a Director (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sika	220.70	1.61 %	K V
Sonova Hldg	301.40	0.84 %	K V
Kuehne+Nagel Int	204.10	0.54 %	K V
Part Grp Hldg	1’336.00	0.45 %	K V
Alcon	76.70	0.42 %	K V
ABB	49.53	-0.88 %	K V
Roche Hldg G	269.30	-0.92 %	K V
Swiss Re	131.80	-1.09 %	K V
UBS Group	30.00	-1.22 %	K V
Zurich Insur Gr	532.20	-1.44 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Inovio Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten